1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Validation of the classification for type 2 diabetes into five subgroups : a report from the ORIGIN trial
(
- Contribution to journal › Article
- 2020
-
Mark
Effects of dipeptidyl peptidase 4 inhibition on inflammation in atherosclerosis : A 18F-fluorodeoxyglucose study of a mouse model of atherosclerosis and type 2 diabetes
(
- Contribution to journal › Article
-
Mark
Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol
(
- Contribution to journal › Article
- 2019
-
Mark
Integrative analysis of prognostic biomarkers derived from multiomics panels helps discrimination of chronic kidney disease trajectories in people with type 2 diabetes
(
- Contribution to journal › Article
- 2018
-
Mark
In vivo inhibition of nuclear factor of activated T-cells leads to atherosclerotic plaque regression in IGF-II/LDLR -/-ApoB100/100 mice
(
- Contribution to journal › Article